iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Q3FY24 Review: Torrent Pharmaceuticals: Steady performance across all parameters

5 Feb 2024 , 02:28 PM

Torrent Pharmaceuticals (Torrent)’s Q3 performance was steady across all fronts, with revenue growth of 12%/16% cc over the year-ago quarter in India/Brazil and EBITDA margin expansion of ~80 basis points sequentially to ~32%. With 40% organic expansion in India rep team over FY22-24, Torrent’s execution in new launches in the domestic market has been strong. This, along with scale-up in TGx and CHL portfolio, has allowed Torrent to outperform IPM volume growth. Brazil business has also benefited from 3-4 BGx launches p.a. over the past 3 years and Torrent is targeting to add new divisions of Derma/Oncology to its Brazil business over the next few years. 

With low-double-digit growth in India/Brazil business, US launches expected to pick-up from Q1FY25 and Balance Sheet deleveraging, analysts at IIFL Capital Services expect Torrent to deliver 13/22% EBITDA/EPS CAGR over FY24-27. They have tweaked their FY25/26 EPS estimates by 0-1% and have maintained their Buy rating on Torrent. Target Price of ₹2,840 (pegged at ~23x FY26 estimated EBITDA) implies 13% upside.

Related Tags

  • Torrent Pharmaceuticals
  • Torrent Pharmaceuticals Q3
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.